Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “COX-2 Inhibitor”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01269515
What this trial is testing

Immunomodulating Therapy and Improved Vaccination Responses by Cox-2 Inhibitor in HIV-infected Patients

Who this might be right for
HIV
Dag Kvale 60
Testing effectiveness (Phase 2)Study completedNCT00099047
What this trial is testing

Celecoxib in Preventing Multiple Myeloma in Patients With Monoclonal Gammopathy or Smoldering Myeloma

Who this might be right for
Monoclonal Gammopathy of Undetermined SignificanceMultiple MyelomaSmoldering Multiple Myeloma
National Cancer Institute (NCI) 23
Testing effectiveness (Phase 2)Ended earlyNCT02840162
What this trial is testing

Pre-Prostatectomy Celecoxib or Placebo

Who this might be right for
Adenocarcinoma of the ProstateProstate Cancer
OHSU Knight Cancer Institute 34
Not applicableLooking for participantsNCT06535568
What this trial is testing

Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO IV-EPIC 38)

Who this might be right for
Coronary DiseaseHeart DiseasesCardiovascular Diseases+22 more
Fondazione Ricerca e Innovazione Cardiovascolare ETS 576
Not applicableStudy completedNCT00299195
What this trial is testing

Study of Sulindac in Oral Premalignant Lesions

Who this might be right for
Leukoplakia, OralBenign Neoplasms
Memorial Sloan Kettering Cancer Center 63
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07634094
What this trial is testing

Intensive Locoregional Chemoimmunotherapy, Intradermal Autologous Alpha-DC1 Vaccines, and Systemic Pembrolizumab for Advanced-Stage Ovarian Cancer

Who this might be right for
Ovarian Cancer
Kalinski, Pawel, MD, PhD 28
Large-scale testing (Phase 3)UnknownNCT02438709
What this trial is testing

Effect Observation Study of COX-2 Inhibitor to Treat Primary Hypertrophic Osteoarthropathy

Who this might be right for
Primary Hypertrophic Osteoarthropathy
Peking Union Medical College Hospital 30
Testing effectiveness (Phase 2)Study completedNCT00581971
What this trial is testing

Radiosensitization With Celecoxib and Chemoradiation for Head and Neck Cancer

Who this might be right for
Cancer
University of Alabama at Birmingham 30
Testing effectiveness (Phase 2)Ended earlyNCT00073970
What this trial is testing

Celecoxib in Treating Patients With Relapsed Prostate Cancer Following Radiation Therapy or Radical Prostatectomy

Who this might be right for
Prostate Cancer
UNC Lineberger Comprehensive Cancer Center 37
Testing effectiveness (Phase 2)Ended earlyNCT00231829
What this trial is testing

A Pilot Study of Celecoxib in Patients With Grade 2 or 3 Uterine Cancers

Who this might be right for
Uterine Cancer
Mark H. Einstein 23
Post-approval studies (Phase 4)Study completedNCT03704623
What this trial is testing

Parecoxib vs Paracetamol in the Treatment of Acute Renal Colic

Who this might be right for
Acute Renal ColicUreteric Stone
Mansoura University 200
Testing effectiveness (Phase 2)Looking for participantsNCT06839144
What this trial is testing

Inhibiting Beta-adrenergic and COX-2 Signaling During the Perioperative Period to Reduce Ovarian Cancer Progression

Who this might be right for
Ovarian CancerOvarian Cancer Metastatic Recurrent
Tel-Aviv Sourasky Medical Center 60
Post-approval studies (Phase 4)Study completedNCT01479829
What this trial is testing

Cyclooxygenase-2-Inhibitor Combination Treatment for Bipolar Depression

Who this might be right for
Bipolar Depression
Loyola University 100
Testing effectiveness (Phase 2)Ended earlyNCT01067989
What this trial is testing

Low-Dose/Metronomic(LDM)Chemotherapy for Metastatic Breast Cancer

Who this might be right for
ChemotherapyBreast Cancer, Metastatic
HaEmek Medical Center, Israel 22
Post-approval studies (Phase 4)Study completedNCT01022190
What this trial is testing

Prevention of Heterotopic Ossification With Arcoxia After Total Hip Replacement

Who this might be right for
Ossification, Heterotopic
Radboud University Medical Center 42
Early research (Phase 1)Study completedNCT01238185
What this trial is testing

Aspirin Mouthwash in Treating Patients With Oral Leukoplakia

Who this might be right for
Precancerous Condition
Institute of Head and Neck Studies and Education, United Kingdom 40
Post-approval studies (Phase 4)Ended earlyNCT03699293
What this trial is testing

NSAIDs vs. Coxibs in the Presence of Aspirin

Who this might be right for
Rheumatoid ArthritisCardiovascular Diseases
Platelet and Thrombosis Research, LLC 8
Not applicableUnknownNCT00533247
What this trial is testing

Arthroplasty Inflammation Prophylaxis With Celecoxib

Who this might be right for
Postoperative Pain
Zanbilowicz, Adam, DPM MS 200
Large-scale testing (Phase 3)Study completedNCT00113308
What this trial is testing

COX-2 Inhibitor Study In Patients With Rheumatoid Arthritis

Who this might be right for
Arthritis, Rheumatoid
GlaxoSmithKline 2,208
Testing effectiveness (Phase 2)Study completedNCT00101335
What this trial is testing

Celecoxib in Preventing Head and Neck Cancer in Patients With Oral Leukoplakia

Who this might be right for
Head and Neck CancerPrecancerous Condition
Fox Chase Cancer Center
Next Page